Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
dorsaVi Limited ( (AU:DVL) ) has issued an update.
dorsaVi Limited has notified the market of the issue of 62.5 million new unlisted options, each exercisable at $0.075 and expiring on 23 December 2028. The options, which are part of a previously announced transaction and are not intended to be quoted on the ASX, expand the company’s pool of unquoted equity instruments and may provide additional incentive or funding flexibility for the business, with potential dilution implications for existing shareholders if exercised.
The most recent analyst rating on (AU:DVL) stock is a Sell with a A$0.04 price target. To see the full list of analyst forecasts on dorsaVi Limited stock, see the AU:DVL Stock Forecast page.
More about dorsaVi Limited
dorsaVi Limited (ASX: DVL) is an Australian-listed company operating in the medical and wearable sensor technology sector, providing motion analysis and biomechanical assessment solutions that support injury prevention, rehabilitation, and workplace and sports performance monitoring.
Average Trading Volume: 4,899,965
Technical Sentiment Signal: Hold
Current Market Cap: A$33.76M
For an in-depth examination of DVL stock, go to TipRanks’ Overview page.

